Abstract

An attempt to introduce evidence based practice and informed choice for pregnant women is a worthy aim. Women deciding whether to have screening for fetal abnormality, either by ultrasound scanning or biochemical serology, should be given adequate information to allow them to understand fully the advantages, disadvantages, and limitations of the available tests. The separate information leaflets produced for patients and carers, as described by S Oliver and colleagues, are generally good. However, they presume that the evidence on which they are based (primarily randomised controlled trials) is appropriate. This presumption may not be correct. For example, in the largest randomised controlled trial (RADIUS: routine antenatal diagnostic imaging with ultrasound) the end points used to evaluate ultrasound screening performed in the second and third trimesters included …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.